Linking social identity and innovative performance

Last registered on January 29, 2019

Pre-Trial

Trial Information

General Information

Title
Linking social identity and innovative performance
RCT ID
AEARCTR-0003803
Initial registration date
January 29, 2019

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
January 29, 2019, 3:48 AM EST

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

Region

Primary Investigator

Affiliation
Middlesex University

Other Primary Investigator(s)

PI Affiliation
The World Bank

Additional Trial Information

Status
On going
Start date
2017-11-08
End date
2020-10-30
Secondary IDs
Abstract
Collaboration plays an important role in innovative progress. Working together would likely result in better ideas which bring about greater innovation performance. Which factors would promote collaboration? In this project we focus on the role of social identity (Chen at al., 2009, 2011) as a main factor to induce collaboration among immigrants. Following are the research questions:

1. Are individuals are more likely to collaborate with others from their own or related ethnics?
2. Are individuals from minority ethnics likely to work on their own or try to collaborate with those from other majority?
3. Will groups consist of individuals from mixed ethnicities?
External Link(s)

Registration Citation

Citation
Le, Anh H and Nguyen Quang. 2019. "Linking social identity and innovative performance." AEA RCT Registry. January 29. https://doi.org/10.1257/rct.3803-1.0
Former Citation
Le, Anh H and Nguyen Quang. 2019. "Linking social identity and innovative performance." AEA RCT Registry. January 29. https://www.socialscienceregistry.org/trials/3803/history/40805
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2018-09-15
Intervention End Date
2018-10-30

Primary Outcomes

Primary Outcomes (end points)
Innovative performance as measured by quality of the business plans.
Primary Outcomes (explanation)
We are also interested in group's innovative performance by by gender composition.

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
We assign participants into different groups as follows:
TG0: We will randomly assign participants to groups of 3 each. All participants are from the same ethnicity;
TG1: We will randomly assign participants to groups of 3 each. Two are from the majority ethnics; 1 from the minority.
TG2: We will randomly assign participants to groups of 3 each. All are from different ethnics.
Experimental Design Details
A group consists of 3 or 4 individuals work together or individually on business idea that is related to social innovation. For example, they could propose a business plan, which supports the poor from the local. Then each individual can decide to work on her or his own, or to collaborate with other individuals in the same group. All groups (individuals) have one month to develop the business plans. Once completed, they can send their business plans for a completion. The award of the first prize would be 10,000 USD.
Innovation performance will then be evaluated by the score given to the business plans.

Group assignment:
We assign participants into different groups as follows:
TG0: We will randomly assign participants to groups of 3 each. All participants are from the same ethnicity;
TG1: We will randomly assign participants to groups of 3 each. Two are from the majority ethnics; 1 from the minority.
TG2: We will randomly assign participants to groups of 3 each. All are from different ethnics.
Randomization Method
We will use an R written program to randomise individuals to various groups.
Randomization Unit
We conduct the randomization at the individual level.
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
576 individuals in three provinces.
Sample size: planned number of observations
576 individuals
Sample size (or number of clusters) by treatment arms
We assign 192 individuals to each treatment arms: TG0, TG1, and TG2.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
N/A
IRB Approval Date
2018-02-15
IRB Approval Number
N/A

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials